Explore more publications!

Press Releases

EU ambassadors hold emergency talks over Trump’s Greenland tariffs

EU ambassadors hold emergency talks over Trump’s Greenland tariffs

Schumer to Halt Trump's Proposed Tariffs on Europe

Schumer to Halt Trump's Proposed Tariffs on Europe

UK PM denounces Trump’s plan to impose tariffs on UK, European NATO

UK PM denounces Trump’s plan to impose tariffs on UK, European NATO

Democratizing Data Architecture: Ellie Technologies Launches Ellie Solo
Next-generation sailors take centre stage at the Monaco Optimist Team Race
Virtune AB (Publ) ("Virtune") has completed the rebalancing for December 2025 of its Virtune Stablecoin Index ETP
TTW Unveils Top 50 Airports in Europe for 2026
Europe Contract Catering Market Set for USD 70.73 Bn Growth as Demand Shifts Across Corporate, Healthcare, and Education
Global  Alkyl Ketene Dimer (AKD)  Market Dynamics 2026–2036: Risk Assessment, Supply Chain Insights & Market Trajectory
Villa Dubrovnik Awarded Green Globe Gold Certification
VÆB Turn Positivity Into Pop Gold on Joyful New Single 'Þetta Reddast'
Folk Americana Roots Hall of Fame Announces Performers and Presenters for Induction Celebration
Electric Vehicle Fleet Management Market Surges to $32.25 billion by 2030 | CAGR 22.7%
AXA and ICEYE strike ‘landmark’ deal to use ultra-high-quality SAR data to track extreme weather events
Lavrov Says NATO Wants Direct War with Russia

Lavrov Says NATO Wants Direct War with Russia

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)
Defiance Launches LNOK: The First Daily 2X Long ETF for Nokia Oyj
The Arctic This Week Take Five: Week of 12 January, 2026

The Arctic This Week Take Five: Week of 12 January, 2026

Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities
Herantis Pharma - Phase 1b biomarker data show clear evidence of biological response to HER-096 in people with Parkinson's disease

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions